In C2C12 myotubes, the ratio of rotenone treatment to control in glucose utilization did not alter with DN‐AMPK adenoviruses infection, although that of lactate release decreased from 2.0‐ to 1.7‐fold (Fig. S1D and F). The gene discussed is PRKAA2; the disease is infection.